Multistate Outbreak of Listeriosis Linked to Turkey Deli Meat and Subsequent Changes in US Regulatory Policy
Open Access
- 1 January 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (1) , 66-72
- https://doi.org/10.1086/498509
Abstract
Background. Data about the efficacy and tolerability of linezolid for the treatment of gram-positive bacterial infections in patients with end-stageKeywords
This publication has 35 references indexed in Scilit:
- Pharmacokinetic studies of linezolid and teicoplanin in the critically illJournal of Antimicrobial Chemotherapy, 2005
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Pharmacokinetics of Linezolid in Subjects with Renal DysfunctionAntimicrobial Agents and Chemotherapy, 2003
- Mechanisms for Linezolid-Induced Anemia and ThrombocytopeniaAnnals of Pharmacotherapy, 2003
- Linezolid: The First Oxazolidinone AntimicrobialAnnals of Internal Medicine, 2003
- Linezolid versus Vancomycin for the Treatment of Methicillin‐ResistantStaphylococcus aureusInfectionsClinical Infectious Diseases, 2002
- Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solutionKidney International, 2002
- Pharmacokinetics and Tissue Penetration of Linezolid following Multiple Oral DosesAntimicrobial Agents and Chemotherapy, 2001
- LinezolidDrugs, 2001
- Vancomycin-Resistant Enterococci among Chronic Hemodialysis Patients: A Prospective Study of AcquisitionClinical Infectious Diseases, 2001